Skip to main content

Table 3 Comparison of EBV expression in Hodgkin lymphoma with other countries in South Asia

From: Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters

Country

Reference

Total positive cases of Hodgkin lymphoma

Lymphocyte rich

Lymphocyte depleted

Mixed cellularity

Nodular sclerosis

Korea

Park et al. [20]

17/25 (68%)

–

–

11/13 (85%)

5/8 (62%)

Saudi Arabia

Armstrong et al. [23]

7/8 (88%)

–

–

5/5 (100%)

2/2 (100%)

Pakistan

Fatima S et al. [26]

50/100 (50%)

0/6(0%)

–

41/57(71%)

19/35(54.2%)

China

Zhou XG et al. [21]

17/28 (60.7%)

–

0/1 (0%)

10/11(90.9%)

6/14(%)

India

Karnic S et al. [24]

82/100(82%)

–

–

–

43/50(86%)

Jordan

Sughayer MA et al. [25]

41/94(43.6%)

0/2(0%)

 

21/26(80.8%)

20/66(30.3%)

Malaysia

Peh SC et al. [22]

41/67(61.2%)

–

1/1 (100%)

27/31(87.1%)

12/33(36.4%)

Pakistan (our study)

Hashmi AA et al.

31/65(47.7%)

2/5(40%)

2/3(66.7%)

17/23(73.9%)

10/15(66.7%)